Granules gets American drug regulator's nod for diabetes management drug Metformin

The US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg, Granules said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2LsKTAX
via IFTTT